ETFs - Profile

Virtus LifeSci Biotech Clinical Trials ETF

US > Health/Biotechnology >

Rank

Universe Rank
20 23

Summary

Philosophy Strategy Process Reaserch Risk Management

Price

  • Last Close
  • $45.99
    -1.33
  • 52 Week HL
  • $61.92 - $38.54
  • Net Assets
  • Expense Ratio

Portfolio

  • Holdings
  • -
  • Turnover Ratio
  • -

Performance
-8.4 % YTD

  • 3 Year
  • 97.99%
  • 5 Year
  • 105.29%
  • Best
  • 63.71%
    2019
  • Worst
  • -36.63%
    2016

Returns +
A

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
BBC -8%32%64%-18%56%-37%5%0%0%0%0%
S&P 500 19%16%29%-6%19%10%-1%11%30%13%0%

Returns +
Q

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Q1 2.3% -23% 22.6% 15.3% 26% -34.4% 18.4% - - - -
Q2 -4% 47.4% -0.6% 6.6% 3.6% -5.5% 10.3% -100% - - -
Q3 -5.3% -9.8% -18.3% 4% 21.4% 25.8% -27.2% -100% - - -
Q4 - 28.8% 59.7% -31.2% -3.3% -18.7% 10.7% 3.9% - - -

Returns +
M

J F M A M J J A S O N D
2021 4% 4.1% -5.5% -1.5% -4.1% 1.6% -9.7% 7.1% -3.7% - - -
2020 -7% -3.8% -14% 20.8% 16.2% 5% -0.3% -6.1% -3.6% -0.5% 21.1% 6.9%

Annual Return

Index Comparison

Alpha

NAV